Orgenesis Inc. (ORGS) SEC Filing 8-K Material Event for the period ending Tuesday, May 17, 2022

Orgenesis Inc.

CIK: 1460602 Ticker: ORGS

View differences made from one to another to evaluate Orgenesis Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Orgenesis Inc..


Assess how Orgenesis Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Orgenesis Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Material Contracts, Statements, Certifications & more

Orgenesis Inc. provided additional information to their SEC Filing as exhibits

Ticker: ORGS
CIK: 1460602
Form Type: 8-K Corporate News
Accession Number: 0001493152-22-014180
Submitted to the SEC: Tue May 17 2022 4:20:34 PM EST
Accepted by the SEC: Tue May 17 2022
Period: Tuesday, May 17, 2022
Industry: Pharmaceutical Preparations
  1. Financial Exhibit
  2. New Agreement
  3. New Financial Obligation
  4. Unregistered Sales

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: